286 |
My Experience of TAVR Using Cusp Overlap View for Self-Expanding THV |
Cheol Woong Yu |
Apr. 12. 21 |
285 |
TAVR Failure Due to Structural Valve Degeneration |
Vinayak Bapat |
Apr. 12. 21 |
284 |
My Experience Focusing on Cusp Overlap View |
Ju Han Kim |
Apr. 12. 21 |
283 |
How to Reduce PPI Rate with Cusp Overlap Technique |
Hemal Gada |
Apr. 12. 21 |
282 |
Antiplatelets Only Sufficient: TAVR Antithrombotics Less is More |
George D. Dangas |
Apr. 12. 21 |
281 |
Transcatheter Mitral Valve Repair: Guideline Changes, Evidence Gaps and Future Directions |
Gregg W. Stone |
Apr. 12. 21 |
280 |
TAVR Long Journey: Chain of RCTs, Guideline Changes, and Future Directions |
Martin Bert Leon |
Apr. 12. 21 |
279 |
Coronary Access Post TAVI |
Danny Dvir |
Apr. 12. 21 |
278 |
Minimizing Embolic Events: Latest TAVR Data |
Eberhard Grube |
Apr. 12. 21 |
277 |
New Insights from the COAPT: Patient Eligibility and Timing |
Gregg W. Stone |
Aug. 06. 20 |